title: Vascular disease: vorapaxar prevents progression of peripheral artery disease.
authors: William R
authors: WR
authors: Hiatt
mesh_terms: D018450:Disease Progression; D006801:Humans; D007511:Ischemia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D007783:Lactones / Q000627:therapeutic use*; D035002:Lower Extremity / Q000098:blood supply*; D058729:Peripheral Arterial Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014654:Vascular Patency / Q000187:drug effects
chemical_list: D007783:Lactones; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; C530299:vorapaxar
references: Circulation. 2013 Apr 9;127(14):1522-9, 1529e1-6
references: 23501976
references: JAMA. 2009 May 13;301(18):1909-19
references: 19436018
references: Cochrane Database Syst Rev. 2011 Nov 09;(11):CD001272
references: 22071801
references: Circulation. 2011 Nov 1;124(18):2020-45
references: 21959305
references: BMJ. 2002 Jan 12;324(7329):71-86
references: 11786451
references: BMJ. 1994 Jan 15;308(6922):159-68
references: 8312766
references: Lancet. 2009 May 30;373(9678):1849-60
references: 19482214
references: N Engl J Med. 2012 Apr 12;366(15):1404-13
references: 22443427
references: N Engl J Med. 1992 Feb 6;326(6):381-6
references: 1729621